Exelixis (EXEL) Share-based Compensation (2010 - 2026)

Exelixis' (EXEL) quarterly Share-based Compensation came in at $34.2 million in Q2 2026, up 52.03% year-on-year from $22.5 million in Q2 2025, and up 70.33% quarter-over-quarter from $20.1 million in Q1 2026.

Exelixis (EXEL) Share-based Compensation (2010 - 2026) Analysis & Trends

Exelixis' Share-based Compensation history runs 17 years deep, the most recent figure standing at $34.2 million for Q2 2026.

  • On a quarterly basis, Share-based Compensation rose 52.03% year-over-year to $34.2 million in Q2 2026; TTM through Apr 2026 was $124.7 million, a 566.26% increase from a year earlier, with the FY2026 full-year figure at $113.0 million, up 637.82% from the prior year.
  • Share-based Compensation climbed to $34.2 million in Q2 2026 per EXEL's latest filing, from $20.1 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $91.5 million in Q4 2022 and bottomed at -$52.2 million in Q1 2025.
  • The 5-year median for Share-based Compensation is $19.1 million (2024), against an average of $16.9 million.
  • Across the five-year window, Share-based Compensation plunged 1468.43% in 2022 and jumped 4282.35% in 2025, its largest moves.
  • Year by year, Share-based Compensation stood at $91.5 million in 2022, then sank by 107.12% to -$6.5 million in 2023, then jumped by 828.94% to $47.5 million in 2024, then tumbled by 34.95% to $30.9 million in 2025, then climbed by 10.83% to $34.2 million in 2026.
  • Per Business Quant, the three latest EXEL Share-based Compensation figures stand at $34.2 million (Q2 2026), $20.1 million (Q1 2026), and $30.9 million (Q4 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 6.39 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 9.26 Mn
4 NuCana 279.75 Bn 279.75 Bn - 1.18 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 166.40 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 257.40 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 87.30 Mn
10 Exelixis 14.38 Bn 13.60 Bn 590.86 Mn 34.23 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 34.23 Mn
Apr 3, 2026 34.23 Mn
Jan 2, 2026 20.10 Mn
Jan 2, 2026 20.10 Mn
Oct 3, 2025 30.89 Mn
Oct 3, 2025 30.89 Mn
Jul 4, 2025 39.49 Mn
Jul 4, 2025 39.49 Mn
Apr 4, 2025 22.52 Mn
Apr 4, 2025 22.52 Mn
Jan 3, 2025 -52.18 Mn
Jan 3, 2025 -52.18 Mn
Sep 27, 2024 47.48 Mn
Sep 27, 2024 47.48 Mn
Jun 28, 2024 901,000.00
Jun 28, 2024 901,000.00
Mar 29, 2024 19.11 Mn
Mar 29, 2024 19.11 Mn
Dec 29, 2023 -6.51 Mn
Dec 29, 2023 -6.51 Mn